Yahoo
    Stuttgart - Delayed Quote EUR

    Onco-Innovations Ltd (W1H.SG)

    0.1384 -0.0106 (-7.11%)
    At close: November 2 at 9:56:16 PM GMT+1
    Loading Chart for W1H.SG
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    View More
    Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform

    Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform
    ACCESS Newswire 1mo ago
    Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform

    Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform
    ACCESS Newswire 1mo ago
    IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Islam Mohamed, Chief Medical Officer of Onco-Innovations Ltd.

    IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Islam Mohamed, Chief Medical Officer of Onco-Innovations Ltd.
    GlobeNewswire 1mo ago

    Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
    ACCESS Newswire 2mo ago

    Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
    ACCESS Newswire 3mo ago

    Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing
    ACCESS Newswire 4mo ago

    Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
    ACCESS Newswire 4mo ago
    Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes

    Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes
    GlobeNewswire 4mo ago

    Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
    ACCESS Newswire 4mo ago

    Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization
    ACCESS Newswire 4mo ago

    Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
    ACCESS Newswire 4mo ago
    View More

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: